Loading...
Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?
P-glycoprotein (P-gp) is a key player in the multidrug-resistant phenotype in cancer. The protein confers resistance by mediating the ATP-dependent efflux of an astonishing array of anticancer drugs. Its broad specificity has been the subject of numerous attempts to inhibit the protein and restore t...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The American Society for Pharmacology and Experimental Therapeutics
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3965902/ https://ncbi.nlm.nih.gov/pubmed/24492893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.113.056176 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|